fluorodeoxyglucose f18 has been researched along with Fragile X Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bacchin, R; Salgarello, M; Tamburin, S; Trentin, M; Zanette, G | 1 |
Dobkin, CS; Grady, CL; Hinton, V; Horwitz, B; Mentis, MJ; Moore, CJ; Murphy, DG; Pietrini, P; Rapoport, SI; Schapiro, MB | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Fragile X Syndrome
Article | Year |
---|---|
Brain 18F-FDG and 18F-Flumetamol PET Imaging of Fragile X-Associated Tremor Ataxia Syndrome.
Topics: Aged; Ataxia; Brain; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Fragile X Mental Retardation Protein; Fragile X Syndrome; Humans; Male; Middle Aged; Positron-Emission Tomography; Tremor | 2021 |
Premutation female carriers of fragile X syndrome: a pilot study on brain anatomy and metabolism.
Topics: Adult; Brain; Case-Control Studies; Confounding Factors, Epidemiologic; Female; Fluorodeoxyglucose F18; Fragile X Syndrome; Heterozygote; Humans; Magnetic Resonance Imaging; Mental Disorders; Mutation; Radiopharmaceuticals; Tomography, Emission-Computed | 1999 |